METHODS AND COMPOSITIONS FOR TREATING AND MANAGING ALZHEIMER'S DISEASE

MISFOLDED PROTEIN DETECTION IN THE EYE

LABELING AND DETECTION OF ASC SPECKS

Methods and Dosing Regimens for Preventing or Delaying Onset of Alzheimer's Disease and Other Forms of Dementia and Mild Cognitive Impairment

MASS SPECTROMETRY ANALYSIS OF MARKERS FOR ALZHEIMER'S DISEASE

METHODS AND KITS FOR MEASURING THREE OR MORE TAU EPITOPES

METHODS OF GENERATING BRAIN ORGANOIDS AND REPAIRING NON-VIABLE EMBRYOID BODIES

USE OF DISCOIDIN DOMAIN RECEPTOR 2 IN DIAGNOSIS OF NEURODEGENERATIVE DISEASES, AND RELATED COMPUTER READABLE MEDIUM

CIRCULATING SERUM MICRORNA BIOMARKERS AND METHODS FOR ALZHEIMER'S DISEASE DIAGNOSIS

BIOMOLECULES INVOLVED IN ALZHEIMER'S DISEASE

BIOMARKERS FOR DETECTING AND/OR DETERMINING A TREATMENT REGIMEN FOR ALZHEIMER'S DISEASE

METHOD OF TREATING ALZHEIMER'S DISEASE WITH EXPANDED NATURAL KILLER CELLS

Anti-TDP-43 Binding Molecules

KIT FOR DIAGNOSING ALZHEIMER'S DISEASE AND PHARMACEUTICAL COMPOSITION FOR TREATING ALZHEIMER'S DISEASE

BIOLOGICAL TEST SAMPLING KIT

HIGH PRECISION AND COST-EFFECTIVE MULTIPLEX QUANTIFICATION OF AB40, AB42, P181TAU, P217TAU, NFL, AND GFAP FROM PLASMA AND SERUM

METHODS FOR THE TREATMENT OF SYMPTOMS OF NEUROLOGICAL AND MENTAL HEALTH DISORDERS

COMPOSITION FOR DIAGNOSING COGNITIVE DYSFUNCTION OF COMPANION ANIMAL BY USING NASAL FLUID

METHODS OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISORDERS

BIOMARKER AND RELATED DETECTION KIT FOR ALZHEIMER'S DISEASE

Method for determining risk factors for neurodegenerative diseases in blood

MONOCLONAL ANTIBODIES DIRECTED TO PHOSPHORYLATED PSD95 AND USES THEREOF

METHODS FOR DETECTING B-ISOX PRECIPITATES OR CAPTURED PROTEINS AS BIOFLUID BIOMARKERS

SPATIAL MRNA/PROTEIN CO-ASSAYS USING APTAMERS

IDENTIFICATION OF TDP-43 CRYPTIC EXON-ENCODED NEOEPITOPES AS FUNCTIONAL FLUID BIOMARKERS FOR ALZHEIMER'S DISEASE AND RELATED DEMENTIA

METHOD FOR DETECTING A TAU PROTEIN FRAGMENT IN A SAMPLE

METABOLIC BIOMARKERS IN BLOOD SERUM FOR DIAGNOSIS OF ALZHEIMER'S DISEASE

QUANTIFICATION OF NEUROFILAMENT LIGHT CHAIN IN PHYSIOLOGICAL SAMPLES

DIAGNOSTICS FOR PORPHYROMONAS GINGIVALIS

TDP-43-BINDING SINGLE-STRANDED APTAMERS AND USES THEREOF

GASOTRANSMITTER METABOLITES AND ALZHEIMER'S DISEASE

METHODS AND KITS FOR DETECTION OF AMYLIN-BETA AMYLOID CO-AGGREGATION

PHOSPHO-TAU AGGREGATION-BASED BIOMARKERS FOR ALZHEIMER'S DISEASE DIAGNOSIS, DIFFERENTIATION, AND TREATMENT

METHODS TO DETECT AB PROTEOFORMS AND USE THEREOF

METHODS AND COMPOSITIONS FOR TAUOPATHY DIAGNOSIS AND TREATMENT

METHODS OF TREATING EPILEPSY

MARKER OF ALZHEIMER'S DISEASE AND USE THEREOF

DEEP LEARNING AND SAM-BASED ALZHEIMER'S DISEASE DIAGNOSING METHOD AND SERS SUBSTRATE THEREFOR

DIAGNOSIS OF ALZHEIMER'S DISEASE BY DETECTING AUTO-ANTIBODIES AGAINST Y-BOX BINDING PROTEIN-1 (YB-1)

PHOSPHO-TAU ANTIBODIES AND METHODS OF USE

SKIN BIOMARKER

METHOD FOR PROVIDING INFORMATION FOR PREDICTING RISK GROUP FOR DEVELOPING ALZHEIMER'S DISEASE OR RISK GROUP FOR EARLY ONSET OF ALZHEIMER'S SYMPTOMS, OR RISK GROUP FOR DEVELOPING AMNESTIC MILD COGNITIVE IMPAIRMENT AND/OR PET-POSITIVE RISK GROUP FOR AMYLOID b DEPOSITION, BASED ON EUROPEAN POPULATION DATA

PROTEIN ANTIGEN COMBINATION CONTAINING SERF2 AND APPLICATION THEREOF

METHODS FOR DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE

METHOD FOR DETECTING SOLUBLE OLIGOMERIC AMYLOID BETA

MICROGLIAL CELLS AS THERAPEUTIC TARGETS IN NEURODEVELOPMENTAL DISORDERS

PROTEIN ANTIGEN COMBINATION FOR DETECTION OF ALZHEIMER'S DISEASE AND APPLICATION THEREOF

ANTIBODIES SPECIFIC FOR HYPERPHOSPHORYLATED TAU AND METHODS OF USE THEREOF

MONOCLONAL ANTIBODY COMPOSITION FOR QUANTITATIVE DETECTION OF AMYLOID IN HUMAN BODY FLUID AND USES

METHODS AND KITS FOR ASSESSING ALZHEIMER'S DISEASE

POLY-GA PROTEINS IN ALZHEIMER’S DISEASE

COMPOSITIONS AND METHODS RELATED TO THE METHYLATION OF HISTONE H1.0 PROTEIN

ANTI-RETROVIRAL THERAPIES AND REVERSE TRANSCRIPTASE INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE

BIOLOGICAL DEVICES FOR THE DETECTION OF ALZHEIMER'S DISEASE AND CONCUSSIONS AND METHODS OF USE THEREOF

A BIOMARKER FOR DETERMINING ALZHEIMER'S DISEASE

Biomarkers for Neurodegenerative Disease

METHOD FOR QUANTIFYING ACTIVE OREXIN A

CATABODIES AND METHODS OF USE THEREOF

METHOD OF INHIBITING TAU PHOSPHORYLATION

METHODS FOR DETECTING CSF TAU SPECIES WITH STAGE AND PROGRESSION OF ALZHEIMER'S DISEASE, AND USE THEREOF

AMYLOID BETA DETECTION BY MASS SPECTROMETRY

METHOD OF DETECTING PROTEIN AGGREGATES

Supermere Nanoparticles and Methods of Isolation and Use Thereof

A Beta Biomarker of Alzheimer’s Disease Model Mouse and Analysis Method Thereof

A METHOD FOR REPRODUCIBLE APTAMER SELECTION USED TO IDENTIFY APTAMERS THAT BIND TO UNKNOWN BIOMARKERS

PHAGE MEDIATED IMMUNO-PCR FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE

HETEROARYL COMPOUNDS AND USES THEREOF

METHOD OF INHIBITING TAU PHOSPHORYLATION

ANTIBODY BASED REAGENTS THAT SPECIFICALLY RECOGNIZE TOXIC OLIGOMERIC FORMS OF TAU

SEROLOGICAL ASSAYS FOR PARKINSON'S DISEASE

p53 PEPTIDES AS MARKERS IN THE DIAGNOSIS AND PROGNOSIS OF ALZHEIMER'S DISEASE

DIGESTED DDIT4L PRODUCT AS DIAGNOSTIC MARKER FOR ALZHEIMER'S DISEASE

METHODS FOR DIAGNOSING AND/OR TREATING ALZHEIMER'S DISEASE

Attenuated Total Reflectance-Based Biosensor for Conformation and Secondary Structure Analysis

ANTIBODIES TO AMYLOID BETA

ANIMAL, FUNGAL AND MARINE SOURCES OF CGP AND INCREASED CGP CONCENTRATION FOR DISEASE MANAGEMENT AND FOR TREATMENT OF NON-NEUROLOGICAL AND/OR NEUROLOGICAL CONDITIONS

COMPOSITION FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE COMPRISING PHOSPHOLIPASE C ACTIVATOR AS AN ACTIVE INGREDIENT

DEORPHANIZING ODORS USING SINGLE CELL SEQUENCING

Improved Gamma-Secretase Inhibitor Screening Assays

METHOD FOR DETECTING NEURODEGENERATIVE DISEASE USING SHORT-CHAIN RNA

BCAA-Lowering Compounds for Prevention and/or Treatment of Alzheimer's Disease and Related Disorders

METHOD AND KIT FOR DIAGNOSING ALZHEIMER'S DISEASE BASED ON THE DETECTION OF APOLIPOPROTEIN E

METHODS FOR DETECTING AN INDIVIDUAL AS BEING AT RISK OF DEVELOPING A NEURODEGENERATIVE DISEASE

APP iRNA Compositions and Methods of Use Thereof for Treating or Preventing Diseases Characterized by Enlarged Endosomes

METHODS FOR TAUOPATHY DIAGNOSIS AND TREATMENT

METHOD FOR DETECTING A LIPIDATED PROTEIN VIA FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET)

POLY-GA PROTEINS IN ALZHEIMER’S DISEASE

SYNTHETIC COMPOUND, KIT COMPRISING THE SAME, AND USES THEREOF

COMPOSITIONS AND METHODS FOR CHARACTERIZING AND TREATING NEURODEGENERATIVE DISORDERS

IMMUNOASSAY FOR DETECTING NEURODEGENERATIVE DISEASES PATHOLOGY IN BIOLOGICAL FLUIDS

METHOD FOR THE EARLY DIAGNOSIS OF NEURODEGENERATIVE DISEASES BY MEANS OF QUANTIFICATION OF PRONGF AND DERIVED FORMS THEREOF

METHOD FOR DETECTING ALZHEIMER'S DISEASE, AND DETECTION REAGENT

CO-MAPPING TRANSCRIPTIONAL STATES AND PROTEIN HISTOLOGY

MONOCLONAL ANTIBODIES TARGETING ACETYLATED TAU AND METHODS OF USE THEREOF

ALZHEIMER'S DISEASE BIOMARKER, AND SCREENING METHOD THEREFOR AND APPLICATION THEREOF

METHODS FOR EVALUATING AND IMPROVING COGNITIVE FUNCTION

PEPTIDE T14 FOR BRAAK STAGING

METHODS AND COMPOSITIONS FOR MONITORING PHAGOCYTIC ACTIVITY

RED BLOOD CELL-DERIVED MAGNETIC IMMUNO-PARTICLE AND USE THEREOF

IMMOBILIZED PROTEIN SYSTEM FOR RAPID AND ENHANCED MULTIPLEXED DIAGNOSTICS

DYES FOR ANALYSIS OF PROTEIN AGGREGATION

PHOSPHO-TAU ANTIBODIES AND METHODS OF USE

METHODS AND MATERIALS TO TREAT NEURODEGENERATIVE DISEASE

DIAGNOSING MILD COGNITIVE IMPAIRMENT (MCI), PREDICTING ALZHEIMER'S DISEASE (AD) DEMENTIA ONSET, AND SCREENING AND MONITORING AGENTS FOR TREATING MCI OR PREVENTING DEMENTIA ONSET

Phospho-TAU antibodies and methods of use

METHODS FOR DIAGNOSIS AND PROGNOSIS OF ALZHEIMER'S DISEASE

Hyperspectral Image-Guided Ocular Imager for Alzheimer's Disease Pathologies

SCREENING METHOD AND INDENDITIES OF BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PARKINSONISM AND/OR COGNITIVE IMPAIRMENT

BIOMARKER FOR NEURODEGENERATIVE DISEASES COMPRISING GLYCOTOXIN, SPECIFIC PROTEIN BOUND TO GLYCOTOXIN, OR GLYCOTOXIN-SPECIFIC PROTEIN COMPLEX

Detection of Beta Amyloid Protein as Alzheimer's Disease-Causing Factor in Palatine Tonsil and Use Thereof

COMPONENT ASSAY FOR ALZHEIMER'S DISEASE IN A LIVING SUBJECT

SOLUBLE CD33 AS A BIOMARKER FOR ANTI-CD33 EFFICACY

METHOD FOR DETERMINATION OF HYPERPHOSPHORYLATED TAU IN HUMAN CEREBROSPINAL FLUID BY LC-MS

METHODS AND COMPOSITIONS FOR SCREENING AND TREATING ALZHEIMER'S DISEASE

NOVEL BINDING MOLECULE AND USE THEREOF

NOVEL THERAPEUTIC PEPTIDES FOR NEURODEGENERATION

BLOOD-BASED ASSAY FOR DETECTING TAUOPATHY OR AMYLOIDOGENIC DISEASE

METHODS FOR DIAGNOSING AND DIFFERENTIATING SYNUCLEINOPATHIES

COMPOSITIONS AND METHODS RELATED TO K180 DIMETHYLATED H1.0 PROTEIN

SEPTAPEPTIDES ASSOCIATED WITH NEURODEGENERACY

SENSOR

METHOD FOR ANALYZING NEUROGRANIN-RELATED PEPTIDE

METHODS AND SYSTEMS FOR DIAGNOSING DISEASES

P53 POST-TRANSLATIONAL MODIFICATIONS AS MARKERS IN THE DIAGNOSIS AND PROGNOSIS OF A NEURODEGENERATIVE DISEASE

MACROCYCLIC MODULATORS OF DISEASE ASSOCIATED PROTEIN MISFOLDING AND AGGREGATION

CIRCULATING SERUM MICRORNA BIOMARKERS AND METHODS FOR ALZHEIMER'S DISEASE DIAGNOSIS

METHOD OF INCREASING CHAPERONE MEDIATED AUTOPHAGY BY STABILIZING THE INTERACTION OF RETINOIC ACID RECEPTOR-ALPHA AND AN INHIBITOR

METHOD FOR DETECTING NEUROLOGICAL DISEASES USING SUPRAMOLECULE POLYMER THERAPEUTICS

METHODS AND MATERIALS FOR DETECTING MISFOLDED POLYPEPTIDES

DETECTION OF BIOMARKERS ON VESICLES FOR THE DIAGNOSIS AND PROGNOSIS OF DISEASES AND DISORDERS

HUMAN INSULIN C-ALPHA-PEPTIDES AND METHODS OF USE

CLEARANCE ASSAY

Biofluid-Based Methods for Diagnosing Alzheimer’s Disease-Associated Conditions

TEST FOR MILD COGNITIVE IMPAIRMENT

METHODS AND SYSTEMS FOR DIAGNOSING DISEASES

ANTIBODY BINDING A LINEAR EPITOPE OF HUMAN P53 AND DIAGNOSTIC APPLICATIONS THEREOF

METHOD OF INHIBITING TAU PHOSPHORYLATION

TREM2 AGONIST BIOMARKERS AND METHODS OF USE THEREOF

TEST KIT FOR TESTING BIOMARKERS OF ALZHEIMER DISEASE AND THE METHOD THEREOF

ANTI-PT217 TAU ANTIBODY

IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID beta (Abeta) AMINO ACID SEQUENCES AND USES THEREOF

COMPOSITIONS, KITS, AND METHODS FOR DETECTING PRECLINICAL ALZHEIMER'S DISEASE

ANTI-TAU ANTIBODIES AND METHODS OF USE

p53 Peptides as Markers in the Diagnosis and Prognosis of Alzheimer's Disease

METHOD BY WHICH BIOSENSOR DEVICE DETECTS ANTIGEN BY USING MULTIPLE FREQUENCIES

NOVEL BIOMARKER FOR DIAGNOSIS OF ALZHEIMER'S DISEASE, DISCOVERED FROM BLOOD-DERIVED EXOSOMES, AND METHOD FOR DIAGNOSING ALZHEIMER'S DISEASE USING SAME

ENGINEERED PICOBODY TO ALPHA SYNUCLEIN

OMEGA-3 FATTY ACID AND VITAMIN D LEVELS TO IDENTIFY AND ATTENUATE COGNITIVE AGING IN INDIVIDUALS

DEVICE AND METHOD FOR IDENTIFYING PEPTIDES AND PROTEINS IN A FLUID SAMPLE

AMYLOID-SPECIFIC ANTIBODIES AND USES THEREOF

METHODS OF DIAGNOSING ALZHEIMER'S DISEASE AND RISK OF PROGRESSION TO ALZHEIMER'S DISEASE

THERAPEUTIC MODULATION OF ALCAM/CD166

METHOD FOR DETECTING MILD COGNITIVE IMPAIRMENT AND MILD ALZHEIMER'S DISEASE

DIAGNOSTIC ASSAYS EMPLOYING NEURON-DERIVED EXOSOMES

Precision Targeted Retromer Therapeutics for the Treatment of Neurodegenerative Diseases and Disorders

Integrated microfluidic system for automated multiplex analyte detection

Protein Damage in Aging and Age-Related Diseases

HETEROARYL COMPOUNDS AND USES THEREOF

RF biosensor and manufacturing method thereof

METHODS, COMPOSITIONS, AND KITS FOR DETECTING AND MEASURING ENDOTHELIAL INJURY IN NORMAL AND DISEASED HUMAN CENTRAL NERVOUS SYSTEM (CNS)

METHOD FOR DETERMINING DISEASE CAUSED BY SYNAPTIC DYSFUNCTION OR DISEASE ACCOMPANIED BY SYNAPTIC DYSFUNCTION

Tau Immunotherapy

NOVEL BLOOD CELL BIOMARKER FOR LATE ONSET ALZHEIMER'S DISEASE

Targeting ligands for tau pathology

THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS, AND ASSOCIATED BIOMARKERS BASED ON TRK-B

BLOOD-BASED SCREEN FOR DETECTING NEUROLOGICAL DISEASES IN PRIMARY CARE SETTINGS

MARKER OF CALCIUM-OVERLOAD-MEDIATED NEURONAL DEATH AND APPLICATION THEREOF

Treatment of Alzheimer's Disease with Allogeneic Mesenchymal Stem Cells

COMPOSITIONS AND METHODS THAT ATTENUATE COGNITIVE AGING IN INDIVIDUALS WHO DO NOT HAVE DEMENTIA

A DIAGNOSTIC BLOOD TEST METHOD FOR THE DETECTION OF ALZHEIMER'S DISEASE

IMMOBILIZED PROTEIN SYSTEM FOR RAPID AND ENHANCED MULTIPLEXED DIAGNOSTICS

DETECTION OF PHOSPHOINOSITIDES IN BLOOD CELLS AS A BIOMARKER FOR ALPHA SYNUCLEIN ASSOCIATED PATHOLOGIES AND A METHOD OF TREATMENT OF PARKINSON'S DISEASE AND THE RELATED NEURODEGENERATIONS

CSF PHOSPHORYLATED TAU AND AMYLOID BETA PROFILES AS BIOMARKERS OF TAUOPATHIES

ANTIBODIES TO alpha-SYNUCLEIN AND USES THEREOF

Methods, Systems & Kits for Prediction, Detection, Monitoring & Treatment of Alzheimer's Disease

Method for diagnosis based on circulating extracellular vesicles

SYSTEM

CATABODIES AND METHODS OF USE THEREOF

ANTIBODIES RECOGNIZING TAU

METHOD OF IDENTIFYING BIOMARKERS OF NEUROLOGICAL DISEASES AND DIAGNOSIS OF NEUROLOGICAL DISEASES

LZHEIMER'S DISEASE-SPECIFIC ALTERATIONS OF PROTEIN KINASE C EPSILON (PKC-EPSILON PROTEIN LEVELS

MONOCLONAL ANTIBODIES AGAINST PATHOLOGICAL TAU, AND METHODS USING SAME

A DRUG SCREENING PLATFORM FOR ENDOSOMAL ENHANCERS TO TREAT ALZHEIMER'S DISEASE

DETERMINATION OF DISEASE-SPECIFIC PROTEIN AGGREGATES IN STOOL SAMPLES

METHODS FOR IDENTIFYING PRE-DISPOSITION TO COGNITIVE DECLINE AND AGENTS FOR REDUCING OR PREVENTING COGNITIVE DECLINE, OR IMPROVING COGNITIVE ABILITY

HUMAN ALZHEIMER'S DISEASE AND TRAUMATIC BRAIN INJURY ASSOCIATED TAU VARIANTS AS BIOMARKERS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR POLYPEPTIDE ANALYSIS

TAU EPITOPE AND BINDING MOLECULES

DIAGNOSIS METHODS, DIAGNOSTIC AGENTS, AND THERAPEUTIC AGENTS AGAINST ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION, AND SCREENING METHODS FOR THESE AGENTS

BIOMARKER FOR DIAGNOSIS OF DEMENTIA

NON-HUMAN MAMMAL MODEL OF HUMAN DEGENERATIVE DISORDER, USES THEREOF, AND METHOD OF TREATING HUMAN DEGENERATIVE DISORDER

METHOD FOR IMMUNOASSAY OF AMYLOID BETA IN BLOOD, AND KIT FOR SAME

BLOOD-BASED DIAGNOSTIC ASSAYS FOR ALZHEIMER'S DISEASE

METHODS OF DETECTING circRNA

PROBES FOR IMAGING B-AMYLOID AND INHIBITION OF B-AMYLOID AGGREGATION

Uses of Tau Phosphosites as Biomarkers for Alzheimer's Disease

IMMUNOTHERAPEUTIC MODULATION OF AMYLOIDOGENIC DISEASE USING NON-FIBRILLOGENIC, NON-AMYLOIDOGENIC POLYMERIZED PROTEINS AND PEPTIDES

ANTIBODY FOR DETECTING ACETYLATION OF COX2 PROTEIN, AND USES THEREOF

COMPOSITION FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE COMPRISING PHOSPHOLIPASE C ACTIVATOR AS AN ACTIVE INGREDIENT

Lymphocyte-Based PKCe Test for Alzheimer's Disease

METHODS FOR DETECTING PROTEINS ASSOCIATED WITH AD

TWO-PHOTON FLUORESCENT PROBE COMPOUND SELECTIVE FOR AMYLOID BETA PLAQUES AND METHOD FOR IMAGING AMYLOID BETA PLAQUES USING SAME

METHODS FOR DETERMINING PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) AND ITS USE FOR DIAGNOSTIC PURPOSE

LACTOFERRIN FOR USE IN THE DIAGNOSIS OR PROGNOSIS OF ALZHEIMER'S DISEASE, OR IN THE DIAGNOSIS OF PARKINSON'S DISEASE

Diagnosing a Disease Associated with Synaptic Degeneration using an Elisa for Determining a Beta-Synuclein Concentration in CSF

p53 POST-TRANSLATIONAL MODIFICATIONS AS MARKERS IN THE DIAGNOSIS AND PROGNOSIS OF A NEURODEGENERATIVE DISEASE

HETEROARYL COMPOUNDS AND USES THEREOF

NEW TAU SPECIES

COMPOSITIONS AND METHODS THAT ATTENUATE COGNITIVE AGING IN INDIVIDUALS WHO DO NOT HAVE DEMENTIA

BLOOD-BASED ASSAY FOR DIAGNOSING AND TREATING BASED ON SITE-SPECIFIC TAU PHOSPHORYLATION

CSF-BASED PROGNOSTIC BIOMARKERS IN ALZHEIMER'S DISEASE AND METHODS OF USE THEREOF

Silver Nanoneedles for Sustained DC Current Single Nanopore Measurements

METHODS OF TREATING DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE WITH PROTECTIVE PROTEIN/CATHEPSIN A (PPCA)

METHOD OF DETECTING A NEURODEGENERATIVE DISEASE

Generation of a new site-specific monoclonal antibody for tau protein and its use as a tool in specific biomarkers for early detection of neurodegenerative diseases and pathologies

TEST STRIP AND METHOD FOR DETECTING AMYLOID BETA IN URINE

Lymphocyte-Based Morphometric Test for Alzheimer's Disease

AMYLOID BETA OLIGOMER DETECTION METHOD, AMYLOID BETA OLIGOMER DETECTION DEVICE, AND AMYLOID BETA OLIGOMER DETECTION PROGRAM

Chimeric protein in the treatment of amyloidosis

Amyloid beta detection by mass spectrometry

Methods and compositions for monitoring phagocytic activity

HERV INHIBITORS FOR USE IN TREATING TAUOPATHIES

IN VITRO DIAGNOSTIC METHOD FOR ALZHEIMER'S DISEASE BASED ON THE ALBUMIN REDOX LEVEL IN THE CEREBROSPINAL FLUID

GENETIC VARIANTS FOR DIAGNOSIS OF ALZHEIMER'S DISEASE

Anti-TDP-43 Binding Molecules and Uses Thereof

BIOMARKER FOR ALZHEIMER'S DISEASE

METHODS TO DETECT MTBR TAU ISOFORMS AND USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISEASES

Targeting ligands for tau pathology

ASSAYS FOR DETECTING AND QUANTIFYING A BIOMARKER OF PERICYTE INJURY

Novel Diagnostic Marker for Creutzfeldt-Jakob Disease and Alzheimer's Disease

METHOD FOR IDENTIFYING CARBOHYDRATE DRUG-SENSITIVE PATIENT IN PATIENTS HAVING ALZHEIMER'S DISEASE

DARPin REAGENTS THAT DISTINGUISH ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE SAMPLES

ß-AMYLOID CYCLIC RIBONUCLEIC ACID, POLYPEPTIDE, AND APPLICATION THEREOF

METHOD FOR TREATING ALZHEIMER'S DISEASE BY INHIBITING UPTAKE OF AMINO ACIDS BY T CELLS

MONOCLONAL ANTIBODY AGAINST AMYLOID BETA, AND METHOD FOR MEASURING AMYLOID BETA-RELATED PEPTIDE USING SAID ANTIBODY

METHODS FOR TREATING RAN PROTEIN-ASSOCIATED NEUROLOGICAL DISEASES

TAU EPITOPE AND BINDING MOLECULES

A BIOMARKER FOR ALZHEIMER'S DISEASE USING BLOOD SAMPLES FROM CLINICALLY DIAGNOSED ALZHEIMER'S DISEASE SUBJECTS

Method of detecting cognitive impairment

Methods of treating epilepsy

BLOOD INDICATORS OF ALZHEIMER'S DISEASE

BIOMARKER FOR DIAGNOSIS OF CEREBRAL NERVOUS SYSTEM DISEASES

DIAGNOSTIC METHOD BASED ON LARGE SCALE IDENTIFICATION OF POST-TRANSLATIONAL MODIFICATION OF PROTEINS

NEURODEGENERATIVE DISEASE THERAPIES UTILIZING THE SKIN-BRAIN AXIS

ANTIBODY DIRECTED AGAINST THE APOE AMINO-TERMINAL FRAGMENT OF 12KDA

Methods for Evaluation and Treatment of Alzheimer's Disease and Applications Thereof

ANTIBODY ARRAY FOR MEASURING A PANEL OF AMYLOIDS

Quantification of neurofilament light chain in physiological samples

METHOD FOR DETECTING OR MONITORING THE DEVELOPMENT OF A CHRONIC DEGENERATIVE DISEASE BY IMMUNOASSAY

METHODS AND MEANS FOR STRATIFICATION OF AN INDIVIDUAL SUFFERING FROM, OR SUSPECTED TO SUFFER FROM, A PROGRESSIVE NEURODEGENERATIVE DISEASE

STRATIFICATION BY SEX AND APOE GENOTYPE IDENTIFIES METABOLIC HETEROGENEITY IN ALZHEIMER'S DISEASE

Antibodies specific for hyperphosphorylated tau and methods of use thereof

COMPOSITIONS AND METHODS FOR CHARACTERIZING AND TREATING ALZHEIMERS DISEASE

HIGH-AFFINITY CU(I) LIGANDS AND METHODS OF USE THEREOF

Molecularly-imprinted electrochemical sensors

METHOD FOR DIAGNOSING ALZHEIMER'S DISEASE USING SILVER NANOGAP SHELL

COMPOUNDS AND METHODS TARGETING HUMAN TAU

DETECTION OF MISFOLDED TAU PROTEIN

METHOD AND KIT FOR MEASURING APP669-711

METHODS AND SYSTEMS FOR IDENTIFYING MODULATORS OF PERVASIVE DEVELOPMENTAL DISORDERS

Methods for Diagnosing Alzheimer's Disease Based on Cell Growth Rate, Size and Protein Amount

NOVEL BIOMARKER FOR ALZHEIMER'S DISEASE IN HUMAN

IN VITRO METHOD FOR THE DIAGNOSIS OR PROGNOSIS OF NEURODEGENERATIVE DISORDERS

MODULATION OF LC3-ASSOCIATED ENDOCYTOSIS PATHWAY AND GENETICALLY MODIFIED NON-HUMAN ANIMALS AS A MODEL OF NEUROINFLAMMATION AND NEURODEGENERATION

Composition for predicting clinical stage of Alzheimer's disease and kit using the same

Blood state analysis apparatus, blood state analysis system, blood state analysis method, and program

METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES

Antibody binding a linear epitope of human P53 and diagnostic applications thereof

DIAGNOSING AND TREATING ALZHEIMERS DISEASE

METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

METHODS AND COMPOSTIONS OF DETECTING AND TREATING NEURODEGENERATIVE DISORDERS

METHOD FOR THE DIAGNOSIS OF AMYLOID-ASSOCIATED DISEASES

BLOOD-BASED ASSAY FOR DETECTING TAUOPATHY OR AMYLOIDOGENIC DISEASE

ANTIBODY CONJUGATE

PROTEIN-BASED THERAPY AND DIAGNOSIS OF TAU-MEDIATED PATHOLOGY IN ALZHEIMER'S DISEASE

BIOMARKERS FOR THE DIAGNOSIS AND CHARACTERIZATION OF ALZHEIMER'S DISEASE

METHOD FOR MEASURING Aß PEPTIDE

PROTEIN ANTIGEN COMBINATION, DETECTION METHOD AND TESTING KIT USING THE SAME

METHODS AND COMPOSITIONS COMPRISING TAU OLIGOMERS

Alzheimer's Disease Assay in a Living Patient

METHOD FOR DETECTING SOLUBLE OLIGOMERIC AMYLOID BETA

Anti-Tau antibodies and methods of use

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

COMPOSITIONS AND METHODS OF DIAGNOSIS AND TREATMENT FOR NEUROLOGICAL DISEASES

METHODS FOR DETECTING DISORDERS RELATED TO CALCIUM DISCHARGE FROM INTRACELLULAR STORES

SYSTEM AND METHOD FOR PROTEIN CORONA SENSOR ARRAY FOR EARLY DETECTION OF DISEASES

Compositions and methods related to the methylation of histone H1.0 protein

Method of Performing Differential Diagnosis of Neurodegenerative Diseases in a Subject

Metabolic biomarkers for memory loss

USE OF Aß34 TO ASSESS ALZHEIMER’S DISEASE PROGRESSION

Gasotransmitter metabolites and Alzheimer's disease

METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF NEUROLOGICAL AND MENTAL HEALTH DISORDERS

Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of Alzheimer's disease

METHODS FOR IDENTIFYING PRE-DISPOSITION TO COGNITIVE DECLINE AND AGENTS FOR REDUCING OR PREVENTING COGNITIVE DECLINE, OR IMPROVING COGNITIVE ABILITY

Parallel Enzyme Digestion for Protein Biomarker Detection

BLOOD-BASED SCREEN FOR DETECTING NEUROLOGICAL DISEASES IN PRIMARY CARE SETTINGS

Compounds useful as near-infrared fluorescent probes selectively binding to tau aggregates and method of preparing the same

METHODS AND DOSING REGIMENS FOR PREVENTING OR DELAYING ONSET OF ALZHEIMER'S DISEASE AND OTHER FORMS OF DEMENTIA AND MILD CONGNITIVE IMPAIRMENT

Heteroaryl compounds and uses thereof